Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Atara Biotherapeutics (ATRA) Tax Provisions (2022 - 2025)

Atara Biotherapeutics (ATRA) has disclosed Tax Provisions for 4 consecutive years, with $28000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Tax Provisions rose 264.71% year-over-year to $28000.0, compared with a TTM value of $12000.0 through Sep 2025, down 33.33%, and an annual FY2024 reading of -$12000.0, down 180.0% over the prior year.
  • Tax Provisions was $28000.0 for Q3 2025 at Atara Biotherapeutics, up from $3000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $28000.0 in Q3 2025 and bottomed at -$19000.0 in Q3 2023.
  • Average Tax Provisions over 4 years is $4181.8, with a median of $3000.0 recorded in 2025.
  • Peak annual rise in Tax Provisions hit 450.0% in 2023, while the deepest fall reached 290.0% in 2023.
  • Year by year, Tax Provisions stood at $2000.0 in 2022, then surged by 450.0% to $11000.0 in 2023, then crashed by 272.73% to -$19000.0 in 2024, then skyrocketed by 247.37% to $28000.0 in 2025.
  • Business Quant data shows Tax Provisions for ATRA at $28000.0 in Q3 2025, $3000.0 in Q2 2025, and -$19000.0 in Q4 2024.